Asia Breast Cancer Screening Market Analysis Report 2023-2028: With a Focus on Improving Healthcare Outcomes, China is Poised to Make Significant Strides in Screening and Prevention
16 janv. 2024 04h58 HE
|
Research and Markets
Dublin, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The "Asia Breast Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Blackford and See-Mode Partner to Bring AI Breast and Thyroid Detection Software to the Blackford Platform
10 janv. 2024 16h30 HE
|
Blackford
Blackford and See-Mode Partner to Add AI Breast and Thyroid Detection Software to the Blackford Platform
Breast Biopsy Market Set to Achieve US$ 3.8 Billion in Revenue by 2033, Report by Persistence Market Research
09 janv. 2024 12h10 HE
|
Persistence Market Research
New York, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Breast biopsy is a medical procedure involving the removal of a sample of breast tissue for diagnostic examination. It is a crucial step in the early...
BRCA Tests Market Regulatory, Reimbursement and Forecasts to 2033
09 janv. 2024 11h03 HE
|
Research and Markets
Dublin, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The "BRCA Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033" report has been added to ResearchAndMarkets.com's offering....
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
09 janv. 2024 10h25 HE
|
FN Media Group LLC
PALM BEACH, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to the report titled "Aging in the United States," published by the Population Reference Bureau, "the...
Olema Oncology Nominates OP-3136, an Orally Bioavailable KAT6 Inhibitor, as a Development Candidate
08 janv. 2024 08h12 HE
|
Olema Oncology
OP-3136 demonstrated potent anti-tumor activity alone and in combination with both palazestrant and CDK4/6 inhibitors in preclinical ER+ breast cancer models Initiating IND-enabling studies with goal...
Olema Oncology to Present at 42nd Annual J.P. Morgan Healthcare Conference
02 janv. 2024 16h01 HE
|
Olema Oncology
SAN FRANCISCO, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...
Breast Cancer Drugs Global Market Report 2024, Featuring Profiles of Key Players Novartis, AstraZeneca, Eli Lilly, Biocon, Merck and MacroGenics
14 déc. 2023 11h03 HE
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Breast Cancer Drugs Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The breast cancer drugs market size is set to to...
Europe Breast and Prostate Cancer Diagnostics Industry is estimated to reach US$ 5,030.1 Million by 2033 Amid Growing Research on Biomarkers | FMI Study
11 déc. 2023 05h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The Europe breast and prostate cancer diagnostics industry is estimated to reach US$ 4,041.5 million in 2023 and US$ 5,030.1 million by 2033. Over the...
Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s
08 déc. 2023 16h05 HE
|
Onconova Therapeutics, Inc.
Onconova Therapeutics’ Preclinical Narazaciclib Data at SABCS Highlights Differentiated Anti-Tumor Activity v. Other CDK4/6i’s